Jason D. Speake
32Patents
3h-index
75Co-inventors
66Inventor score
Filing activity: Apr 28, 2000 → Feb 11, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7285557B2 | Pyrimidinones as melanin concentrating hormone receptor 1 | Chemistry; Metallurgy | 9 | Expired |
| US7442693B2 | Diazepine compounds as ligands of the melanocortin 1 and/or 4 receptors | Chemistry; Metallurgy | 7 | Expired |
| US9420793B2 | Antiparasitic compounds | Chemistry; Metallurgy | 6 | Active |
| US8809397B2 | Nicotinic receptor non-competitive antagonists | Chemistry; Metallurgy | 3 | Active |
| US9686991B2 | Antiparasitic compounds | Chemistry; Metallurgy | 3 | Active |
| US7368453B2 | Quinazolinone compounds with reduced bioaccumulation | Chemistry; Metallurgy | 3 | Expired |
| US8476296B2 | Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]OCT-3-yl)-3,5-difluorobenzamide | Chemistry; Metallurgy | 3 | Active |
| US10092001B2 | Antiparasitic compounds | Chemistry; Metallurgy | 2 | Active |
| US8901151B2 | Preparation and therapeutic applications of (2S, 3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]OCT-3-yl)-3,5-difluorobenzamide | Chemistry; Metallurgy | 2 | Active |
| US9883674B2 | Antiparasitic compounds | Chemistry; Metallurgy | 2 | Active |
| US6884801B1 | Imidazoline derivatives as alpha-1A adrenoceptor ligands | Chemistry; Metallurgy | 1 | Expired |
| US9532974B2 | Nicotinic receptor non-competitive antagonists | Chemistry; Metallurgy | 1 | Active |
| US10961261B2 | Oxaborole analogs and uses thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US8633175B2 | Compounds as antagonists or inverse agonists at opioid receptors | Chemistry; Metallurgy | 1 | Active |
| US9173876B2 | Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide | Chemistry; Metallurgy | 1 | Active |
| US10258582B2 | Nicotinic receptor non-competitive antagonists | Chemistry; Metallurgy | 1 | Active |
| US11459331B2 | Chemical compounds | Human Necessities | 0 | Active |
| US10570144B2 | Substituted ureas as prostaglandin EP4 receptor antagonists | Chemistry; Metallurgy | 0 | Active |
| US10556909B2 | Synthetic process and intermediates | Human Necessities | 0 | Active |
| US7625909B2 | Substituted quinazolinone compounds | Chemistry; Metallurgy | 0 | Expired |
| US10772331B2 | Antiparasitic compounds | Chemistry; Metallurgy | 0 | Active |
| US9643963B2 | Antiparasitic compounds | Emerging Cross-Sectional Technologies | 0 | Active |
| US8822518B2 | Compounds as antagonists or inverse agonists of opioid receptors for treatment of addiction | Chemistry; Metallurgy | 0 | Active |
| US10807992B2 | Single enantiomer antiparasitic compounds | Human Necessities | 0 | Active |
| US10744136B2 | Sulfonamide derivatives as JAK inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.